The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
Authors
Keywords
-
Journal
Pathogens
Volume 11, Issue 4, Pages 431
Publisher
MDPI AG
Online
2022-04-03
DOI
10.3390/pathogens11040431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing
- (2022) Rohit Sharma et al. Frontiers in Cellular and Infection Microbiology
- Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
- (2022) Nevien Ismail et al. Frontiers in Immunology
- Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis
- (2022) Greta Volpedo et al. npj Vaccines
- Characterization of a new Leishmania major strain for use in a controlled human infection model
- (2021) Helen Ashwin et al. Nature Communications
- Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
- (2021) Brima M. Younis et al. MOLECULAR THERAPY
- Leishmaniasis: where are we and where are we heading?
- (2021) Santanu Sasidharan et al. PARASITOLOGY RESEARCH
- Revival of Leishmanization and Leishmanin
- (2021) Thalia Pacheco-Fernandez et al. Frontiers in Cellular and Infection Microbiology
- From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
- (2021) Greta Volpedo et al. Expert Review of Vaccines
- Human leishmaniasis vaccines: Use cases, target population and potential global demand
- (2021) Stefano Malvolti et al. PLoS Neglected Tropical Diseases
- Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
- (2021) Greta Volpedo et al. Frontiers in Cellular and Infection Microbiology
- Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
- (2021) Subir Karmakar et al. Communications Biology
- The potential of live attenuated vaccines against Cutaneous Leishmaniasis
- (2020) A. Zabala-Peñafiel et al. EXPERIMENTAL PARASITOLOGY
- Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis
- (2020) Satish Chandra Pandey et al. PARASITE IMMUNOLOGY
- Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates
- (2020) Fabiano Oliveira et al. Scientific Reports
- A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
- (2020) Wen-Wei Zhang et al. Nature Communications
- Post kala-azar dermal leishmaniasis: A threat to elimination program
- (2020) Mallikarjuna Rao Gedda et al. PLoS Neglected Tropical Diseases
- Human challenge models: tools to accelerate the development of malaria vaccines
- (2019) Martha M. Cooper et al. Expert Review of Vaccines
- Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
- (2019) Beatriz Coutinho De Oliveira et al. Human Vaccines & Immunotherapeutics
- A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice
- (2018) Ashley M. Vaughan et al. INFECTION AND IMMUNITY
- Peptide Vaccines for Leishmaniasis
- (2018) Rory C. F. De Brito et al. Frontiers in Immunology
- Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
- (2018) Negar Seyed et al. Frontiers in Immunology
- Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200–CD200R Immune Inhibitory Axis
- (2018) Rakesh K. Singh et al. Frontiers in Immunology
- Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice
- (2018) Ana Maria Murta Santi et al. Scientific Reports
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
- (2018) Malcolm S. Duthie et al. Frontiers in Immunology
- Macrophage Polarization in Leishmaniasis: Broadening Horizons
- (2018) Fernanda Tomiotto-Pellissier et al. Frontiers in Immunology
- Live AttenuatedLeishmania donovaniCentrin Gene–Deleted Parasites Induce IL-23–Dependent IL-17–Protective Immune Response against Visceral Leishmaniasis in a Murine Model
- (2017) Antara Banerjee et al. JOURNAL OF IMMUNOLOGY
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
- (2017) Mohamed Osman et al. PLoS Neglected Tropical Diseases
- Immunization with Live Attenuated Leishmania donovani Centrin−/− Parasites Is Efficacious in Asymptomatic Infection
- (2017) Nevien Ismail et al. Frontiers in Immunology
- DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control
- (2016) A. Kumar et al. PARASITE IMMUNOLOGY
- Possibilities and challenges for developing a successful vaccine for leishmaniasis
- (2016) Saumya Srivastava et al. Parasites & Vectors
- Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen−/−)
- (2016) Kelvinson Fernandes Viana et al. Parasites & Vectors
- Status of vaccine research and development of vaccines for leishmaniasis
- (2016) Portia M. Gillespie et al. VACCINE
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
- (2016) Kimia Kardani et al. VACCINE
- Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
- (2016) Parna Bhattacharya et al. PLoS Neglected Tropical Diseases
- Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
- (2016) Kumar Avishek et al. Scientific Reports
- Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice
- (2015) Parna Bhattacharya et al. INFECTION AND IMMUNITY
- Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
- (2015) Jacqueline Araújo Fiuza et al. VACCINE
- Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control
- (2014) O. P. Singh et al. CLINICAL INFECTIOUS DISEASES
- Immunization of Mice with Live-Attenuated Late Liver Stage-Arresting Plasmodium yoelii Parasites Generates Protective Antibody Responses to Preerythrocytic Stages of Malaria
- (2014) Gladys J. Keitany et al. INFECTION AND IMMUNITY
- Characterization of Cross-Protection by Genetically Modified Live-AttenuatedLeishmania donovaniParasites againstLeishmania mexicana
- (2014) Ranadhir Dey et al. JOURNAL OF IMMUNOLOGY
- A Next-generation Genetically Attenuated Plasmodium falciparum Parasite Created by Triple Gene Deletion
- (2014) Sebastian A Mikolajczak et al. MOLECULAR THERAPY
- Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis
- (2014) Angamuthu Selvapandiyan et al. VACCINE
- Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
- (2014) Sreenivas Gannavaram et al. Frontiers in Immunology
- Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
- (2013) R. Dey et al. JOURNAL OF IMMUNOLOGY
- Leishmaniasis: clinical syndromes and treatment
- (2013) B. S. McGwire et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Case study for a vaccine against leishmaniasis
- (2013) Jorge Alvar et al. VACCINE
- Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs
- (2013) Jacqueline Araújo Fiuza et al. VACCINE
- Genetic engineering of attenuated malaria parasites for vaccination
- (2012) Shahid M Khan et al. CURRENT OPINION IN BIOTECHNOLOGY
- CCR7+ Central and CCR7− Effector Memory CD4+ T Cells in Human Cutaneous Leishmaniasis
- (2012) Hossein Keshavarz Valian et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Evaluation of Recombinant Leishmania Polyprotein Plus Glucopyranosyl Lipid A Stable Emulsion Vaccines against Sand Fly-Transmitted Leishmania major in C57BL/6 Mice
- (2012) N. C. Peters et al. JOURNAL OF IMMUNOLOGY
- Immunity to Sand Fly Salivary Protein LJM11 Modulates Host Response to Vector-Transmitted Leishmania Conferring Ulcer-Free Protection
- (2012) Regis Gomes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Leishmaniasis: Vaccine candidates and perspectives
- (2012) Bhawana Singh et al. VACCINE
- KSAC, a Defined Leishmania Antigen, plus Adjuvant Protects against the Virulence of L. major Transmitted by Its Natural Vector Phlebotomus duboscqi
- (2012) Regis Gomes et al. PLoS Neglected Tropical Diseases
- The influence of early neutrophil-Leishmania interactions on the host immune response to infection
- (2012) Flavia L. Ribeiro-Gomes et al. Frontiers in Cellular and Infection Microbiology
- The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response
- (2012) Dong Liu et al. Frontiers in Cellular and Infection Microbiology
- Vaccine Development Against Leishmania donovani
- (2012) Amrita Das et al. Frontiers in Immunology
- Radiofrequency-induced heat therapy as first-line treatment for cutaneous leishmaniasis
- (2011) Ram A Bumb et al. Expert Review of Anti-Infective Therapy
- Vaccine candidates for leishmaniasis: A review
- (2011) Rajeev Nagill et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation
- (2011) Javier Carrión et al. Parasites & Vectors
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- The development and clinical evaluation of second-generation leishmaniasis vaccines
- (2011) Malcolm S. Duthie et al. VACCINE
- Lutzomyia longipalpis Saliva or Salivary Protein LJM19 Protects against Leishmania braziliensis and the Saliva of Its Vector, Lutzomyia intermedia
- (2011) Natalia M. Tavares et al. PLoS Neglected Tropical Diseases
- Diagnosis of visceral leishmaniasis
- (2010) Pankaj Srivastava et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis
- (2010) Alejandro Llanos-Cuentas et al. VACCINE
- Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis
- (2009) A. Selvapandiyan et al. JOURNAL OF IMMUNOLOGY
- Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
- (2009) Nicolas Collin et al. PLoS Pathogens
- Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
- (2009) Nathan C. Peters et al. PLoS Pathogens
- Live attenuated Leishmania vaccines: a potential strategic alternative
- (2008) Ricardo Silvestre et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Vaccines for leishmaniasis in the fore coming 25 years
- (2008) Clarisa B. Palatnik-de-Sousa VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now